Sygehusene i Næstved, Slagelse og Ringsted

Medicin og biovidenskab

1. Denmark 100%
2. Knee Osteoarthritis 84%
3. Randomized Controlled Trials 59%
4. Cohort Studies 53%
5. Knee Replacement Arthroplasties 49%
6. Asthma 49%
7. Chronic Obstructive Pulmonary Disease 44%
8. Systematic Reviews 44%
9. Type 2 Diabetes Mellitus 41%
10. Pain 40%
11. Knee 38%
12. Hip Osteoarthritis 37%
13. Exercise 36%
14. Exercise Therapy 35%
15. Neuromyelitis Optica 34%
16. Arthroplasty 32%
17. Population 32%
18. Osteoarthritis 32%
19. Therapeutics 31%
20. Mortality 29%
21. Hip 29%
22. Child 27%
23. Prospective Studies 27%
24. Pregnancy 27%
25. Meta-Analysis 27%
26. Confidence Intervals 26%
27. Quality of Life 24%
28. Lung 21%
29. Registries 21%
30. Rehabilitation 21%
31. Observational Studies 20%
32. Cross-Sectional Studies 20%
33. Incidence 19%
34. Comorbidity 18%
35. Suburban Population 17%
36. Optic Neuritis 17%
37. Guidelines 16%
38. Education 16%
39. Health 16%
40. Cardiac Rehabilitation 15%
41. Odds Ratio 15%
42. Delivery of Health Care 15%
43. Referral and Consultation 15%
44. Multimorbidity 14%
45. Anti-Bacterial Agents 14%
46. Hypothyroidism 14%
47. Placebos 14%
48. Heart Failure 14%
49. Multicenter Studies 14%
50. Stroke 14%
51. Coronavirus 14%
52. Hospital Emergency Service 14%
53. Hypersensitivity 13%
54. Acetaminophen 13%
55. Hermeneutics 13%
56. Transferrin 13%
57. Magnetic Resonance Imaging 13%
58. Hospitalization 12%
59. Adrenal Cortex Hormones 12%
60. Inflammatory Bowel Diseases 12%
61. Primary Health Care 12%
62. Colorectal Neoplasms 12%
63. Neoplasms 12%
64. Knee Injuries 12%
65. Iron 12%
66. Infections 11%
67. Intensive Care Units 11%
68. Databases 11%
69. Fish Oils 11%
70. Lung Neoplasms 11%
71. Microbiota 10%
72. Sepsis 10%
73. Multiple Sclerosis 10%
74. Cardiovascular Diseases 10%
75. Tears 10%
76. Feasibility Studies 10%
77. Health Care Outcome Assessment 10%
78. Gastrointestinal Microbiome 10%
79. Femoral Nerve 10%
80. Parturition 10%
81. Hemochromatosis 9%
82. Hip Fractures 9%
83. Rheumatoid Arthritis 9%
84. Body Mass Index 9%
85. Palliative Care 9%
86. Chronic Pain 9%
87. Carotid Endarterectomy 9%
88. Pulmonologists 9%
89. Crohn Disease 9%
90. Fine Needle Biopsy 9%
91. Interviews 9%
92. Azithromycin 9%
93. Cost-Benefit Analysis 9%
94. Pre-Eclampsia 8%
95. Nerve Block 8%
96. Unsaturated Fatty Acids 8%
97. Aquaporin 4 8%